FDA finds no cancer link with blood pressure pills

Jun 02, 2011

(AP) -- The Food and Drug Administration says there is no link between a popular group of blood pressure medications and cancer, despite a recent paper suggesting a slightly higher risk in patients taking the drugs.

In an analysis of 60,000 patients published last summer, experts found a link between people taking medicines known as angiotensin-receptor blockers and cancer. The drugs are taken by millions of people worldwide for conditions like , heart problems and .

But the FDA says its own review of 31 studies involving 155,000 patients did not show any relationship between the drugs and cancer. The review is the largest of its kind, according to the FDA

The drugs are sold under brand names including Diovan, Micardis and Avapro.

Explore further: More than a quarter of emergency contraceptives in Peru falsified or substandard

not rated yet
add to favorites email to friend print save as pdf

Related Stories

FDA panel backs anemia drugs for kidney disease

Oct 18, 2010

(AP) -- Federal health advisers say patients with failing kidneys should continue taking a group of widely used anemia drugs, despite a recent study showing they can increase the risk of stroke.

FDA: Arthritis drugs pose cancer risk to children

Aug 04, 2009

(AP) -- Federal regulators on Tuesday added stronger warnings to a group of best-selling drugs used to treat arthritis and other inflammatory diseases, saying they can increase the risk of cancer in children and adolescents.

FDA questions safety of Glaxo kidney cancer drug

Oct 01, 2009

(AP) -- Federal regulators said Thursday an experimental kidney cancer drug from GlaxoSmithKline may cause liver problems, potentially outweighing its ability to slow the disease.

High blood pressure pill cuts risk of Parkinson's disease

Feb 06, 2008

People taking a widely used group of drugs known as calcium channel blockers to treat high blood pressure also appear to be cutting their risk of Parkinson’s disease, according to a study published in the February 6, 2008, ...

Recommended for you

Study recalculates costs of combination vaccines

Apr 17, 2014

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Drug watchdog urges vigilance in cancer drug theft

Apr 17, 2014

Europe's medicine watchdog urged doctors Thursday to be vigilant in administering the cancer drug Herceptin, vials of which had been stolen in Italy and tampered with before being sold back into the supply chain.

User comments : 0

More news stories

Teachers' scare tactics may lead to lower exam scores

As the school year winds down and final exams loom, teachers may want to avoid reminding students of the bad consequences of failing a test because doing so could lead to lower scores, according to new research published ...